Eli Rosenberg

Eli Rosenberg
Associate Professor
Epidemiology & Biostatistics

Contact

1 University Place, Room 123
Education

PhD, Epidemiology, Emory University Rollins School of Public Health (2012)

Dr. Rosenberg smiles at the camera.
About

Dr. Rosenberg is an associate professor in the Department of Epidemiology and Biostatistics who is committed to infectious diseases epidemiological work to improve the health of persons in New York State and nationally. His research centers on applied and analytic epidemiologic studies that address current public health challenges in HIV, STI, viral hepatitis, and emerging infectious diseases, with a  focus on surveillance, prevention, and social determinants. He has specifically focused on sexual and racial minorities, persons who inject drugs, and the infectious disease disparities they face, with considerable effort spent on cohort and modeling studies. This work has occurred across a diverse portfolio of projects supported by NIH, CDC, and NYS Department of Health.

Since March 2020, Rosenberg has been providing technical assistance to the State of New York’s COVID-19 response across a range of activities and studies addressing critical aspects of SARS-CoV-2 transmission, surveillance, prevention, and treatment. He has been providing expertise on COVID-19 epidemiology to Governor Cuomo’s office, the SUNY system, the University at Albany, and in numerous local and national media appearances.

 

Current major activities:

  • Characterizing the COVID-19 epidemic in New York State. Since the COVID-19 epidemic unfolded in New York during March 2020, our group has been working closely with the New York State Department of Health and others to rapidly conduct studies on the natural history, treatment, social determinants, and extent of transmission of COVID-19. These high-impact studies have been establishing an evidence base from New York to inform other states, the US, and countries as they address the pandemic. See Google Scholar for recent publications.

 

 

  • University at Albany COVID-19 Surveillance Testing Program. Led by Drs. Andy Berglund of the RNA Institute and Udo and Rosenberg of the School of Public Health, this program is a cornerstone of University at Albany’s COVID-19 health strategy. This program is testing the whole campus community for SARS-CoV-2 infection on an ongoing basis, using a saliva-based assay combined with a public health testing strategy.

 

  • Projects to support Governor Cuomo and NYS Department of Health’s initiative to eliminate Hepatitis C in New York State. Together with Dr. Tomoko Udo, our team is conducting a series of activities to support the first state-level HCV elimination initiative in the United States, including:

  1. Upstate Study for Infectious Disease Elimination (UPSIDE) - a project to understand HIV and HCV prevalence, risk, and care among persons who inject drugs in 3 upstate New York communities.

  2. Evaluating pilot studies of innovative models for HCV care delivery – We are conducting the program evaluation for 3 AIDS Institute-funded pilot programs to integrate HCV care into syringe exchange programs, in order to increase HCV treatment levels among PWID.

  3. Coordination of data and metrics for the NYS Hepatitis C elimination initiative - In order to monitor progress towards 2030 elimination goals, an enhanced program of data and metrics needs to be developed. We are coordinating the design of this system and will take a leading role in the annual data and progress reporting. ·

 

  • Coalition for Applied Modeling for Prevention (CAMP) - A broad and prolific portfolio of economic and epidemic modeling projects for directing national, state, and local disease prevention activities across HIV, viral hepatitis, STD, tuberculosis, and school health. Now in its second round of funding by the CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CAMP is led by UAlbany in close collaboration with teams at Emory University, Johns Hopkins University, University of Washington, Georgia State University, and UC San Diego.

 

Sample of recently completed studies:

  • Ele[men]t - A cohort study of HIV-negative young black MSM ages 18-29 in Atlanta to deepen understanding of the relationships between substances and HIV/STI incidence and risk behaviors, while providing real-world HIV pre-exposure prophylaxis implementation data. Funded by NIH/NIDA.
  • Zika Persistence Study (Ziper) – A cohort study in Puerto Rico during the 2016-2017 Zika epidemic to understand the duration of detection of Zika in a variety of body fluids. This project contributed crucial epidemiological data crucial for informing guidelines for Zika diagnosis and prevention. The primary findings for Ziper can be found here. Funded and conducted by CDC.
  • Involve[men]t - A cohort study that examined the individual, dyadic, and community level risk differences between black and white MSM in Atlanta, in order to explain the disparity in HIV and STI prevalence and incidence. The primary findings from Involvement can be found here. Funded by NIH/NIMH.
  • Modeling Approaches to Racial Disparities in Atlanta MSM (MARDHAM) - An agent-based modeling study of the HIV epidemic among MSM in Atlanta that aims to understand the drivers of the racial disparities in HIV infection. The primary findings from MARDHAM can be found here. Funded by NIH/NICHD.

 

Teaching:

  • EPI 502: Principles and Methods of Epidemiology II
  • EPI 612: Quantitative Methods in Epidemiology

 

Learn more about Dr. Rosenberg's work: 

 

Other Affiliations:

  • Senior epidemiologist, Centers for Disease Control and Prevention (CDC)
  • Adjunct associate professor, Emory University Rollins School of Public Health, Department of Epidemiology and PRISM Health group, where he was primarily appointed from 2013-2017.